FindTrial
Sign In

Behavioural Activation for Comorbid Depression in Non-communicable Disease (BEACON) study

Behavioural activation for depression in people with non-communicable disease in low- and middle-income countries in South Asia: Protocol for intervention design and randomised controlled feasibility trial - BEACON

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025048
Enrollment
168
Registered
2020-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus Health Condition 2: I00-I99- Diseases of the circulatory system Health Condition 3: J00-J99- Diseases of the respiratory system Health Condition 4: F32- Major depressive disorder, singleepisode

Interventions

Intervention1: BEACON intervention: Individual therapy, delivered by a trained health worker, supported by a treatment manual and workbooks, and supervision by a specialist Control Intervention1: Leaf

Sponsors

Dr Arun Kandasamy
Lead Sponsor
Prof Pratima Murthy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Aged 18 years or over Diagnosed with cardiovascular disease, chronic respiratory disease or diabetes (type 1 or 2) Current diagnosis of depression (confirmed with a clinician-administered PHQ-9 score of � 10)48 Willing to participate and able to attend therapy sessions in person or by telephone Other mental or physical illness comorbidities will not be a reason to exclude unless the patient is judged to be too unwell to participate

Exclusion criteria

Exclusion criteria: Already receiving psychotherapy for depression. Being on antidepressant medication will not however be a reason to exclude. Lacking capacity to provide informed consent Unable to take part in therapy because of cognitive impairment, or severity of mental or physical illness

Design outcomes

Primary

MeasureTime frame
A refined BA intervention, BEACON, including intervention manual, workbooks and training package, ready for trial intervention An optimised protocol for evaluation of effectiveness and cost effectiveness of BEACON for depression in NCD in LMIC, including an intervention fidelity framework and protocols for process evaluationTimepoint: Baseline and 3 months—

Secondary

MeasureTime frame
Anxiety (GAD-7) Health related quality of life (EQ-5D-5L) Physical health, using a measure of quality of life and function S(F-36) NCD specific outcomes (HbA1c; Blood Pressure, respiratory quality of life)Timepoint: Baseline and 3 months—

Countries

Bangladesh, India, Pakistan

Contacts

Public ContactDr Arun Kandasamy

NIMHANS

arunnimhans05@gmail.com08026995250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026